MEKTOVI: payments to doctors
Payments that named MEKTOVI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.8M
- Providers
- 8,565
- Transactions
- 34,680
- Average per transaction
- $52
The per-transaction average — $52 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,565 providers the average total is $211, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Array Biopharma Inc | $764,472 | 42.4% |
| Pfizer | $594,825 | 33.0% |
| Array Biopharma Inc. | $444,136 | 24.6% |
| Medivation Services LLC | $130 | 0.0% |
| PBG Puerto RICO LLC | $45 | 0.0% |